CYTK - Cytokinetics, Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income-106,289-127,79016,453-37,501
Operating Activities, Cash Flows Provided By or Used In
Depreciation1,2391,920741589
Adjustments To Net Income26,77123,6247,6624,549
Changes In Accounts Receivables4,035-1,088-1246,634
Changes In Liabilities-26,7252,9703,900-11,987
Changes In Inventories----
Changes In Other Operating Activities-246-1,3958,2382,599
Total Cash Flow From Operating Activities-101,215-101,75936,9824,883
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-889-2,877-1,596-562
Investments6,008-62,951-50,51316,624
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities5,133-65,828-52,07616,063
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings9,8981,26114,99614,890
Other Cash Flows from Financing Activities-90,62190,62190,621
Total Cash Flows From Financing Activities13,132225,91916,89223,915
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents-82,95058,3321,79844,861